-
News
Chief Clinical Officer Appointed to Serve the AdventHealth East Florida Division
Dr. Andrew Weinfeld will be responsible for executing clinical and organizational strategy, improving clinical effectiveness and patient safety, and delivering exceptional patient experiences for the...
-
News
AdventHealth Involved in Research to Evaluate First Potential Disease-Modifying Treatment for Epileptic Patients with Dravet Syndrome
Under the leadership of principal investigator Ki Hyeong Lee, MD, MS, medical director of AdventHealth for Children’s pediatric epilepsy center in Orlando, AdventHealth Orlando has been one of two...
-
News
AdventHealth for Children Collaborating with n-Lorem Foundation to Provide Personalized Treatments to Patients with Nano-rare Genetic Diseases
The n-Lorem Foundation recently selected AdventHealth for Children in Orlando as one of the first institutions in Florida to collaborate with providing personalized antisense oligonucleotide (ASO)...
-
News
AdventHealth Neuroscience Institute Secures New Gamma Knife Radiosurgery Platform to Advance Patient Care
In April 2024, the AdventHealth Neuroscience Institute became the first in Central Florida to treat brain patients with the Elekta Esprit Gamma Knife. This advanced stereotactic radiosurgery (SRS)...
-
News
Innovative Spring Sees Three Groundbreaking Cardiovascular Procedures Performed by AdventHealth Physicians
This spring, AdventHealth marked significant advancements in patient care with three “firsts” representing a leap forward in treatment of cardiovascular conditions.
-
News
AdventHealth Orlando is the First in Central Florida to Randomize a Patient in the Global ALLAY-HF Study for Alleviating Heart Failure Symptoms
Under the leadership of AdventHealth Heart, Lung and Vascular Institute interventional cardiologist Rohit Bhatheja, MD, MBA, FACC, FSCAI, AdventHealth Orlando became the first in Central Florida to...
-
News
Groundbreaking Ozempic study – Conducted in Part at AdventHealth – Could Increase Access for People with Chronic Kidney Disease
A recent study, called FLOW, showed Ozempic had dramatic results in slowing chronic kidney disease progression in participants with Type 2 diabetes.
-
News
Pro Volleyball in Central Florida and Breaking Barriers for Female Athletes
In this episode of the Inspiring Wholeness podcast, Orlando Valkyries head coach Amy Pauly talks with Dr. Nicole Wilson, a Rothman Orthopaedics sports medicine physician at AdventHealth, about...
-
News
United Way, AdventHealth Bring Mental Health Destigmatization Campaign to Hispanic Community
“Lidera ConscienteMENTE" is an adaptation of the "Be a Mindleader" initiative, which, since launching a year ago, has connected hundreds of families to counseling services.
-
News
With Type 1 Diabetes on the Rise, AdventHealth Study Aims to Expand Screening
With type 1 diabetes on the rise, researchers at AdventHealth are trying to identify undiagnosed type 1 diabetes (T1D) in its early stages, in particular among the state’s underserved and minority...